United Therapeutics Newsroom

Argus Research Maintains United Therapeutics(UTHR.US) With Buy Rating, Raises Target Price to $400

Futu NewsOct 31 22:31

United Therapeutics Is Maintained at Buy by Argus Research

Dow JonesOct 31 22:23

Jefferies Maintains United Therapeutics(UTHR.US) With Buy Rating, Maintains Target Price $432

Futu NewsOct 31 21:45

United Therapeutics Analyst Ratings

BenzingaOct 31 21:37

HC Wainwright & Co. Maintains Buy on United Therapeutics, Raises Price Target to $425

BenzingaOct 31 21:35

A Quick Look at Today's Ratings for United Therapeutics(UTHR.US), With a Forecast Between $395 to $600

Futu NewsOct 31 21:18

J.P. Morgan Maintains United Therapeutics(UTHR.US) With Buy Rating, Maintains Target Price $360

Futu NewsOct 29 18:33

United Therapeutics Is Maintained at Buy by TD Cowen

Dow JonesOct 22 01:32

United Therapeutics Analyst Ratings

BenzingaOct 22 01:22

TD Cowen Maintains United Therapeutics(UTHR.US) With Buy Rating, Raises Target Price to $400

Futu NewsOct 21 20:31

Jefferies Initiates United Therapeutics(UTHR.US) With Buy Rating, Announces Target Price $432

Futu NewsSep 24 20:31

Jefferies Maintains United Therapeutics(UTHR.US) With Buy Rating, Raises Target Price to $432

Futu NewsSep 24 00:32

United Therapeutics Analyst Ratings

BenzingaSep 23 23:22

Oppenheimer Maintains Outperform on United Therapeutics, Raises Price Target to $575

BenzingaAug 28 20:59

United Therapeutics Analyst Ratings

BenzingaAug 28 20:58

Oppenheimer Maintains United Therapeutics(UTHR.US) With Buy Rating, Raises Target Price to $575

Futu NewsAug 28 20:32

Leerink Partners Maintains United Therapeutics(UTHR.US) With Buy Rating, Raises Target Price to $375

Futu NewsAug 22 13:32

Morgan Stanley Maintains United Therapeutics(UTHR.US) With Hold Rating, Maintains Target Price $337

Futu NewsAug 21 07:31

United Therapeutics Analyst Ratings

BenzingaAug 21 00:22

Wells Fargo Maintains Overweight on United Therapeutics, Raises Price Target to $380

BenzingaAug 21 00:22